A phase 1 open label study to assess effect of different patch application sites on the relative bioavailability of HP-30703
Latest Information Update: 26 Mar 2021
At a glance
- Drugs Asenapine (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Acronyms Study 2
- 26 Mar 2021 New trial record
- 12 Mar 2021 Results from Three randomized open label studies published in the Journal of Clinical Psychopharmacology